TY - JOUR
T1 - Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma
AU - Barton, Joshua G.
AU - Bois, John P.
AU - Sarr, Michael G.
AU - Wood, Christina M.
AU - Qin, Rui
AU - Thomsen, Kristine M.
AU - Kendrick, Michael L.
AU - Farnell, Michael B.
PY - 2009
Y1 - 2009
N2 - Background Preoperative serum values of CA 19-9 have been reported to be associated with survival in patients undergoing resection of pancreatic adenocarcinoma. Hypothesis Preoperative CA 19-9 levels are associated with margin and/or lymph node status in patients undergoing pancreatoduodenectomy for pancreatic carcinoma. Methods We conducted a review of 143 patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma from July 2001 through April 2006 at our institution. Preoperative serum values of CA 19-9 and total bilirubin, pathologic findings, and survival were analyzed. A cutoff value for CA 19-9 (120 U/ml) was determined using a Cox proportional hazards model for survival. Results Overall survival at 1, 3, and 5 years for patients with CA 19-9≤120 U/ml was 76%, 41%, and 31%, respectively, versus 64%, 17%, and 10% for patients with CA 19-9>120 U/ml (p=0.002). CA 19-9>120 U/ml was not associated, however, with a greater chance of an R1 or R2 resection (p=0.86), tumor involving the SMA margin (p=0.88), tumor at the portal vein groove (p=0.14), or lymph node metastases (p=0.89). Conclusions Our findings do not support a cutoff value for CA 19-9 that is associated with margin or lymph node involvement. Preoperative CA 19-9≤120 U/ml is, however, associated with increased overall and recurrence-free survival.
AB - Background Preoperative serum values of CA 19-9 have been reported to be associated with survival in patients undergoing resection of pancreatic adenocarcinoma. Hypothesis Preoperative CA 19-9 levels are associated with margin and/or lymph node status in patients undergoing pancreatoduodenectomy for pancreatic carcinoma. Methods We conducted a review of 143 patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma from July 2001 through April 2006 at our institution. Preoperative serum values of CA 19-9 and total bilirubin, pathologic findings, and survival were analyzed. A cutoff value for CA 19-9 (120 U/ml) was determined using a Cox proportional hazards model for survival. Results Overall survival at 1, 3, and 5 years for patients with CA 19-9≤120 U/ml was 76%, 41%, and 31%, respectively, versus 64%, 17%, and 10% for patients with CA 19-9>120 U/ml (p=0.002). CA 19-9>120 U/ml was not associated, however, with a greater chance of an R1 or R2 resection (p=0.86), tumor involving the SMA margin (p=0.88), tumor at the portal vein groove (p=0.14), or lymph node metastases (p=0.89). Conclusions Our findings do not support a cutoff value for CA 19-9 that is associated with margin or lymph node involvement. Preoperative CA 19-9≤120 U/ml is, however, associated with increased overall and recurrence-free survival.
KW - CA 19-9 antigen
KW - Pancreatic carcinoma
KW - Pancreatic ductal carcinoma
KW - Predictive value of tests
KW - Survival analysis
UR - http://www.scopus.com/inward/record.url?scp=77952973346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952973346&partnerID=8YFLogxK
U2 - 10.1007/s11605-009-0849-z
DO - 10.1007/s11605-009-0849-z
M3 - Review article
C2 - 19756875
AN - SCOPUS:77952973346
SN - 1091-255X
VL - 13
SP - 2050
EP - 2058
JO - Journal of Gastrointestinal Surgery
JF - Journal of Gastrointestinal Surgery
IS - 11
ER -